251 related articles for article (PubMed ID: 1626492)
1. Review of randomized trials of digoxin therapy in patients with chronic heart failure.
Gheorghiade M; Zarowitz BJ
Am J Cardiol; 1992 Jun; 69(18):48G-62G; discussion 62G-63G. PubMed ID: 1626492
[TBL] [Abstract][Full Text] [Related]
2. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.
Majumdar SR; McAlister FA; Cree M; Chang WC; Packer M; Armstrong PW;
Clin Ther; 2004 May; 26(5):694-703. PubMed ID: 15220013
[TBL] [Abstract][Full Text] [Related]
3. Influence of digitalis on left ventricular functional response to exercise in congestive heart failure.
Morisco C; Cuocolo A; Romano M; Nappi A; Iaccarino G; Volpe M; Salvatore M; Trimarco B
Am J Cardiol; 1996 Mar; 77(7):480-5. PubMed ID: 8629588
[TBL] [Abstract][Full Text] [Related]
4. Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm.
Kromer EP; Elsner D; Riegger GA
J Cardiovasc Pharmacol; 1990 Jul; 16(1):9-14. PubMed ID: 1696671
[TBL] [Abstract][Full Text] [Related]
5. [Digoxin and angiotensin-converting enzyme inhibitors in the treatment of chronic congestive heart failure].
Thery C
Therapie; 1994; 49(3):211-8. PubMed ID: 7878586
[TBL] [Abstract][Full Text] [Related]
6. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.
Gambassi G; Lapane KL; Sgadari A; Carbonin P; Gatsonis C; Lipsitz LA; Mor V; Bernabei R
Arch Intern Med; 2000 Jan; 160(1):53-60. PubMed ID: 10632305
[TBL] [Abstract][Full Text] [Related]
7. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
Massie BM; Berk MR; Brozena SC; Elkayam U; Plehn JF; Kukin ML; Packer M; Murphy BE; Neuberg GW; Steingart RM
Circulation; 1993 Aug; 88(2):492-501. PubMed ID: 8339411
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
Aronow WS
J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
[TBL] [Abstract][Full Text] [Related]
9. Therapy of left ventricular dysfunction: implications of recent therapeutic trials and future directions for therapy.
Pitt B
Schweiz Med Wochenschr; 1993 Feb; 123(8):342-8. PubMed ID: 8095738
[TBL] [Abstract][Full Text] [Related]
10. [Trends in pharmacological treatment of congestive heart failure].
Halawa B
Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
[TBL] [Abstract][Full Text] [Related]
11. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors.
Gheorghiade M; Hall VB; Jacobsen G; Alam M; Rosman H; Goldstein S
Circulation; 1995 Oct; 92(7):1801-7. PubMed ID: 7671364
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentration of Fas/Fas ligand and left ventricular function in response to metoprolol in conjunction with standard treatment.
Hou YP; Wu JL; Fan Q; Liu MB; Yin BL; Zhang L
Clin Sci (Lond); 2007 Mar; 112(5):299-304. PubMed ID: 17020540
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin converting enzyme inhibitors versus digoxin for the treatment of congestive heart failure.
Crozier I; Ikram H
Drugs; 1992 May; 43(5):637-50. PubMed ID: 1379144
[TBL] [Abstract][Full Text] [Related]
15. [Is digoxin effective in the treatment of heart insufficiency in patients with sinus rhythm?].
Henriksen OM; Gadsbøll N
Ugeskr Laeger; 1999 May; 161(22):3269-74. PubMed ID: 10485204
[TBL] [Abstract][Full Text] [Related]
16. Digoxin use in congestive heart failure. Current status.
Riaz K; Forker AD
Drugs; 1998 Jun; 55(6):747-58. PubMed ID: 9617590
[TBL] [Abstract][Full Text] [Related]
17. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
[TBL] [Abstract][Full Text] [Related]
18. From digoxin to angiotensin-converting enzyme inhibitors: issues in pharmacotherapy for congestive heart failure.
Hackenbruck HA
Clin Excell Nurse Pract; 2000 Jul; 4(4):197-204. PubMed ID: 11261079
[TBL] [Abstract][Full Text] [Related]
19. Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme.
Young JB; Gheorghiade M; Uretsky BF; Patterson JH; Adams KF
J Am Coll Cardiol; 1998 Sep; 32(3):686-92. PubMed ID: 9741512
[TBL] [Abstract][Full Text] [Related]
20. Congestive heart failure: what should be the initial therapy and why?
Chatterjee K
Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
